Glioblastoma stem cells downregulate the expression of major histocompatibility complex (MHC) molecules to escape tumor antigen-cognate T lymphocytes, thus inducing an immunosuppressive tumor microenvironment [21, 22]. The gene discussed is HLA-C; the disease is glioblastoma.